Agenus | AGEN - 売上総利益

株価
3.92
毎日の変更
-0.25 -6.00%
毎月
-3.45%
毎年
32.88%
Q2 予測
3.76




売上総利益 変化する 日付
AbbVie USD 12.54B 474M 2026-03
Agenus USD 34.2M 4.61M 2025-12
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
Celldex Therapeutics USD 121K 609K 2025-12
CSL USD 4.46B 2.71B 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 5.75B 429M 2026-03
Glaxosmithkline GBP 8.75B 2.92B 2025-09
Incyte USD 1.17B 217.51M 2026-03
Intrexon USD -297K 167K 2024-06
J&J USD 17.24B 642M 2026-03
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
MacroGenics USD 31.11M 30.14M 2025-12
Merck EUR 2.96B 252M 2025-12
Merck USD 10.85B 2.57B 2025-12
Novartis USD 10.07B 184M 2026-03
Novavax USD 125.04M 76.09M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Veracyte USD 101.16M 814K 2026-03